Definitive Contract 75A50124C00013

This $243,500 firm-fixed-price purchase order was awarded to Instadiagnostics Inc., a minority-owned, for-profit small business, by the Centers for Disease Control and Prevention (CDC) under the Small Business Innovation Research (SBIR) program. The contract is for the development of rapid diagnostic tests and devices related to SBIR Topic 37. Instadiagnostics Inc. has previously received federal grants from the CDC, Department of Defense, and National Institutes of Health for the development of...

This is a $2,100,000.00 Firm Fixed Price (FFP) contract awarded by the U.S. Department of Health and Human Services (HHS), Administration for Strategic Preparedness and Response (ASPR), Center for Industrial Base Expansion and Supply Chain (IBMSC) to Osang LLC, a small disadvantaged business, for the delivery of 1,000,000 commercial off-the-shelf multi-antigen diagnostic test kits capable of detecting SARS-CoV-2 and Influenza A/B. The contract has a 12-month period of performance and is a 100%...

This federal contract award, valued at $30,954,000.00, was made by the Office of the Assistant Secretary for Preparedness and Response to Diasorin Molecular, LLC, a foreign-owned, for-profit medical diagnostics manufacturer based in Cypress, California. The contract is a definitive, firm-fixed-price agreement with a period of performance extending through June 30, 2026. The purpose of this contract is to expand the availability of point-of-care molecular diagnostics in U.S. pharmacies....

This $34,714,763.00 cost-plus-fixed-fee contract was awarded by the Office of the Assistant Secretary for Preparedness and Response (ASPR) to Detect Inc. to advance the development of a second-generation, multi-analyte molecular SARS-CoV-2 and influenza A/B test that has a reduced time to result and increased sensitivity for use at home or in a point-of-care setting. The contract is not set aside. The award references a Broad Agency Announcement (BAA) issued by the Biomedical Advanced Research...

<p>The Department of Health and Human Services Centers for Disease Control and Prevention awarded a definitive, firm-fixed-price contract to Impedx Diagnostics Inc., a for-profit organization, for other functions. The contract has a potential value of $379,680.00 and a completion date of September 29, 2019. The contract was awarded on September 30, 2018, and the place of performance is Overland Park, KS 66212, USA. The contract is not set aside.</p>

This is a $113,182,532.15 definitive contract awarded to Cepheid Inc., a for-profit manufacturer of molecular diagnostic solutions, by the Office of the Assistant Secretary for Preparedness and Response (ASPR) for pandemic preparedness and response. The contract is to establish a platform for diagnosis and surveillance of emerging threats and is not designated with a set-aside. The original solicitation was a Broad Agency Announcement from the Biomedical Advanced Research and Development...

This is a $999,923 Small Business Innovation Research (SBIR) Phase II contract awarded by the Defense Advanced Research Projects Agency (DARPA) to Inflammatix, Inc., a small disadvantaged business in Sunnyvale, California. The contract is for the development of point-of-care diagnostic solutions to monitor the host-pathogen interaction during infection. Inflammatix has been awarded over $29 million in federal contracts and grants from agencies like the Department of Health and Human Services and...

This is a Firm Fixed Price contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. Department of Health and Human Services, to Godx Inc., a minority-owned small business. The $1,596,552.00 contract is for the development of a rapid, low-cost, point-of-care diagnostic test to detect enteric pathogens and antibiotic resistance. The goal is to create a diagnostic tool that can identify cholera, salmonella, shigella, and other...

This is a definitive contract awarded by the Office of the Assistant Secretary for Preparedness and Response (ASPR), a civilian agency within the Department of Health and Human Services, to Selux Diagnostics, Inc. as the prime contractor. The $70,578,261.84 contract is for cost plus fixed fee work and does not have a set-aside designation. The contract involves the development and delivery of products and services to support ASPR's mission. Key subcontractors include Beckman Coulter, Inc. for...

<p>This is a $12,606,489.57 Firm Fixed Price definitive contract awarded by the Office of the Assistant Secretary for Preparedness and Response, a civilian agency, to AD Astra Diagnostics, Inc. for the research and development of a CLIA-waived ubiquitous early sepsis detection and severity assessment system for use in ambulance, pre-hospital, and post-discharge settings. The contract has an ultimate completion date of December 15, 2027 and does not have a set-aside designation.</p>